Cargando…
Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277573/ https://www.ncbi.nlm.nih.gov/pubmed/34277459 http://dx.doi.org/10.3389/fonc.2021.721658 |
Ejemplares similares
-
Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma via Down-Regulating the NF-kB/COX-2/VEGF Pathway
Publicado: (2021) -
Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
por: Liao, Xiaozhong, et al.
Publicado: (2020) -
Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
por: Liao, Xiaozhong, et al.
Publicado: (2021) -
NF-kB and the CLL microenvironment
por: O’Donnell, Alice, et al.
Publicado: (2023) -
Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis
por: Huang, Chien-Yu, et al.
Publicado: (2018)